Sponsors (4)
The bill directs HHS to study and publicly report on services and outcomes for infants with NAS, which could enable better-targeted care and resource allocation over time but does not provide immediate funding or coverage changes and may raise expectations that cannot be quickly met.
Medicaid beneficiaries (infants with neonatal abstinence syndrome) and state programs will get a mapped inventory of services and prevalence data from HHS, enabling better-targeted services and more informed federal/state resource allocation and program design.
Children (infants with NAS) and pregnant women may receive improved care planning because the study examines infant and maternal health outcomes associated with pediatric transitional care facilities.
Medicaid families with NAS-affected infants will likely not see immediate coverage or funding changes because the report is research-based and findings may take up to three years before prompting policy changes.
States and Medicaid beneficiaries could have expectations raised by identified gaps but lack guaranteed federal or state resources to address them, leaving service shortfalls uncorrected.
HHS will need to allocate administrative time and staff to conduct the study and reporting, which could divert federal resources from other tasks or priorities.
Based on analysis of 2 sections of legislative text.
Requires HHS to study NAS in Medicaid populations, identify data barriers and available services in pediatric transitional care facilities, and report publicly to Congress within 3 years.
Requires the Secretary of Health and Human Services to study neonatal abstinence syndrome (NAS) and related infant and maternal outcomes in the context of pediatric transitional care facilities, focusing on data gaps in Medicaid and the scope of services available. The Secretary must deliver a report to Congress and publish it publicly within 3 years of enactment. The study must identify barriers to obtaining accurate, up-to-date NAS prevalence data for Medicaid beneficiaries and describe services and supports provided to beneficiaries diagnosed with NAS under Medicaid state plans or waivers. The measure also defines key terms used in the study.
Introduced November 20, 2025 by Daniel Milton Newhouse · Last progress November 20, 2025